Deb Kientop

Deb Kientop has 10 years of experience in the life sciences industry. Deb began their career in 2008 as President of MSL 360, LLC. In 2012, they joined the Medical Science Liaison Society as an Advisory Committee Member. In 2010, they started at Quintiles as Sr. Director, Oncology Therapeutic Strategy. In 2014, they moved to ICON plc as Senior Director, Oncology Strategy. In 2018, they took on the role of Vice President, Life Sciences at Inteliquet. In 2020, they joined Synteract as Vice President, Oncology Development. In 2021, they became Senior Vice President, Oncology Strategy and Innovation at ERGOMED. Deb also took on the role of Strategic Advisor in 2021. Finally, in 2022, they joined Deka Biosciences, Inc as Vice President Clinical Operations.

Deb Kientop holds a Bachelor of Science in Pharmacology and Toxicology from the University of Wisconsin-Madison, and a Master of Business Administration from the University of Wisconsin Oshkosh. Deb also completed a Professional Certificate in International Business Management from University College Dublin in 2016, and a Certificate in Patient Advocacy from the University of Miami in 2011.